Cancer Drug News Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of secondary cancer
Cancer Drug News New drug hope for prostate cancer patients January 15, 2025 Prostate cancer that has become resistant to hormone therapy could be treated using a new…
Cancer Drug News Generic platinum chemotherapy shortages did not increase deaths December 17, 2024 During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in…
Cancer Drug News European Commission approves tislelizumab for first-line treatment of advanced/metastatic oesophageal squamous cell carcinoma and gastric or gastroesophageal junction cancer December 8, 2024 European Commission has approved tislelizumab in combination with chemotherapy for the first-line treatment of oesophageal squamous…
Cancer Drug News High-tech tracking technology streamlines drug discovery November 15, 2024 New drug discovery is a critical step for improving patients’ lives. First, researchers must identify…
Cancer Drug News FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukaemia November 13, 2024 On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix,…
Cancer Drug News FDA approves zolbetuximab-clzb with chemotherapy for gastric or gastroesophageal junction adenocarcinoma November 12, 2024 Tthe Food and Drug Administration have approved zolbetuximab-clzb, a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, with…
Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies? November 6, 2024 Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2…
Cancer Drug News New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer October 31, 2024 A new drug called WNTinib can delay the growth of tumours and improve survival in…
Breast Cancer Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models October 30, 2024 In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise…
Cancer Drug News Scientists discover chemical probes for previously “undruggable” cancer target October 30, 2024 Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein…